Key facts
- This page summarizes Sarah M. Kauss's Form 4 filing for Thorne Healthtech, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 18 Oct 2023, 16:58.
Sarah M. Kauss - 16 Oct 2023 Form 4 Insider Report for Thorne Healthtech, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 16 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Oct 2023, 16:58:09 UTC
- Prior SEC filing
- 06 Apr 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kim Pearson, under power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Sarah M. Kauss filed Form 4 for Thorne Healthtech, Inc. on 18 Oct 2023.
Change
- Previous filing in this sequence was filed on 06 Apr 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
THRN
transaction
Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -105,874
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 16 Oct 2023
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Sarah M. Kauss is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 1 footnote
Footnote F1
Certain of these shares are represented by previously reported restricted stock units ("RSUs"). At the effective time of the merger contemplated by the Agreement and Plan of Merger between the Issuer, Healthspan Buyer, LLC and Healthspan Merger Sub, Inc., dated as of August 27, 2023 (the "Merger Agreement"), (i) each issued and outstanding RSU was cancelled and converted into the right to receive an amount equal to $10.20 in cash (the "Per Share Price"), subject to the terms set forth in the Merger Agreement, and (ii) each issued and outstanding share of the Issuer's Common Stock was cancelled and converted into the right to receive an amount in cash equal to the Per Share Price.